473 related articles for article (PubMed ID: 35778734)
1. TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients.
Zhao J; Fan H; Wang T; Yu B; Mao S; Wang X; Zhang W; Wang L; Zhang Y; Ren Z; Liang B
Cardiovasc Diabetol; 2022 Jul; 21(1):123. PubMed ID: 35778734
[TBL] [Abstract][Full Text] [Related]
2. A combined analysis of TyG index, SII index, and SIRI index: positive association with CHD risk and coronary atherosclerosis severity in patients with NAFLD.
Dong W; Gong Y; Zhao J; Wang Y; Li B; Yang Y
Front Endocrinol (Lausanne); 2023; 14():1281839. PubMed ID: 38260163
[TBL] [Abstract][Full Text] [Related]
3. Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes.
Li N; Tan H; Xie A; Li C; Fu X; Xang W; Kirim A; Huang X
BMC Endocr Disord; 2022 Apr; 22(1):101. PubMed ID: 35428219
[TBL] [Abstract][Full Text] [Related]
4. Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults.
Li S; Feng L; Ding J; Zhou W; Yuan T; Mao J
BMC Gastroenterol; 2023 Nov; 23(1):376. PubMed ID: 37919650
[TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic fatty liver disease in Tanzania: prevalence, determinants, and diagnostic performance of triglycerides-glucose index and triglycerides-glucose index -body mass index compared to the hepatic ultrasound in overweight and obese individuals.
Kilonzo SB; Kamala E; Jaka H; Ngoya P
BMC Gastroenterol; 2024 Mar; 24(1):96. PubMed ID: 38438930
[TBL] [Abstract][Full Text] [Related]
6. The triglyceride-glucose index is associated with atherosclerosis in patients with symptomatic coronary artery disease, regardless of diabetes mellitus and hyperlipidaemia.
Li J; Dong Z; Wu H; Liu Y; Chen Y; Li S; Zhang Y; Qi X; Wei L
Cardiovasc Diabetol; 2023 Aug; 22(1):224. PubMed ID: 37620954
[TBL] [Abstract][Full Text] [Related]
7. A non-linear relationship between triglyceride glucose waist circumference and nonalcoholic fatty liver disease in a Japanese population: a secondary analysis.
He X; Huang X; Qian Y; Sun T
Front Endocrinol (Lausanne); 2023; 14():1188214. PubMed ID: 37484966
[TBL] [Abstract][Full Text] [Related]
8. Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study.
Li Y; Zheng R; Li J; Feng S; Wang L; Huang Z
Lipids Health Dis; 2020 Oct; 19(1):229. PubMed ID: 33109219
[TBL] [Abstract][Full Text] [Related]
9. Association between triglyceride-glucose index and nonalcoholic fatty liver disease in type 2 diabetes mellitus.
Li W; Wang Y; He F; Liu Z; Dong J; Zhang Y; Li T; Liu S; Chen E
BMC Endocr Disord; 2022 Oct; 22(1):261. PubMed ID: 36289536
[TBL] [Abstract][Full Text] [Related]
10. Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population.
Zeng P; Cai X; Yu X; Gong L
Sci Rep; 2023 Nov; 13(1):20470. PubMed ID: 37993481
[TBL] [Abstract][Full Text] [Related]
11. Relationship Between Six Insulin Resistance Surrogates and Nonalcoholic Fatty Liver Disease Among Older Adults: A Cross-Sectional Study.
Li H; Shi Z; Chen X; Wang J; Ding J; Geng S; Sheng X; Shi S
Diabetes Metab Syndr Obes; 2023; 16():1685-1696. PubMed ID: 37309507
[TBL] [Abstract][Full Text] [Related]
12. Fatty liver biomarkers and insulin resistance indices in the prediction of non-alcoholic fatty liver disease in Ghanaian patients.
Bockarie AS; Nartey YA; Nsiah P; Edzie EKM; Tuoyire D; Acquah S; Eliason S; Nkum B
Endocrinol Diabetes Metab; 2023 Nov; 6(6):e456. PubMed ID: 37814510
[TBL] [Abstract][Full Text] [Related]
13. Association between the Triglyceride-Glucose Index and Non-Alcoholic Fatty Liver Disease in patients with Atrial Fibrillation.
Li X; Zhan F; Peng T; Xia Z; Li J
Eur J Med Res; 2023 Sep; 28(1):355. PubMed ID: 37726807
[TBL] [Abstract][Full Text] [Related]
14. Triglyceride glucose index for the detection of the severity of coronary artery disease in different glucose metabolic states in patients with coronary heart disease: a RCSCD-TCM study in China.
Su J; Li Z; Huang M; Wang Y; Yang T; Ma M; Ni T; Pan G; Lai Z; Li C; Li L; Yu C
Cardiovasc Diabetol; 2022 Jun; 21(1):96. PubMed ID: 35668496
[TBL] [Abstract][Full Text] [Related]
15. The triglyceride-glucose index is associated with the severity of hepatic steatosis and the presence of liver fibrosis in non-alcoholic fatty liver disease: a cross-sectional study in Chinese adults.
Guo W; Lu J; Qin P; Li X; Zhu W; Wu J; Xu N; Zhang Q
Lipids Health Dis; 2020 Oct; 19(1):218. PubMed ID: 33028338
[TBL] [Abstract][Full Text] [Related]
16. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.
Khamseh ME; Malek M; Abbasi R; Taheri H; Lahouti M; Alaei-Shahmiri F
Metab Syndr Relat Disord; 2021 Apr; 19(3):167-173. PubMed ID: 33259744
[No Abstract] [Full Text] [Related]
17. Association between the triglyceride-glucose index and severity of coronary artery disease.
Wang X; Xu W; Song Q; Zhao Z; Meng X; Xia C; Xie Y; Yang C; Jin P; Wang F
Cardiovasc Diabetol; 2022 Sep; 21(1):168. PubMed ID: 36050734
[TBL] [Abstract][Full Text] [Related]
18. Triglyceride glucose index is a useful marker for predicting subclinical coronary artery disease in the absence of traditional risk factors.
Park GM; Cho YR; Won KB; Yang YJ; Park S; Ann SH; Kim YG; Park EJ; Kim SJ; Lee SG; Yang DH; Kang JW; Lim TH; Kim HK; Choe J; Lee SW; Kim YH
Lipids Health Dis; 2020 Jan; 19(1):7. PubMed ID: 31937313
[TBL] [Abstract][Full Text] [Related]
19. Baseline level and change trajectory of the triglyceride-glucose index in relation to the development of NAFLD: a large population-based cohort study.
Wang Y; Wang J; Liu L; Yang P; Deng S; Liu X; Zhao L; Wang C; Li Y
Front Endocrinol (Lausanne); 2023; 14():1137098. PubMed ID: 37223043
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of the triglyceride glucose-body mass index in evaluating nonalcoholic fatty liver disease: insights from a general population.
Wang R; Dai L; Zhong Y; Xie G
Lipids Health Dis; 2021 Jul; 20(1):77. PubMed ID: 34321005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
